Clinical Trials Logo

Clinical Trial Summary

The purpose of this study to investigate the addictive properties of soda and other sugar sweetened beverages (SBBs) in teenagers aged 13-18 years. It is hypothesized that participants who were regularly consuming sweetened and caffeinated beverages will experience symptoms typical of caffeine withdrawal, such as headache and fatigue, during the SSB withdrawal period.


Clinical Trial Description

n/a


Study Design

Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Supportive Care


Related Conditions & MeSH terms


NCT number NCT02044757
Study type Interventional
Source University of California, Berkeley
Contact
Status Completed
Phase N/A
Start date June 2013
Completion date August 2014

See also
  Status Clinical Trial Phase
Recruiting NCT05264428 - The Effect of Honey on Lessening the Withdrawal Symptoms N/A
Completed NCT03557294 - Varenicline OTC Trial on Efficacy and Safety Phase 4
Recruiting NCT04850664 - Computerized Chemosensory-Based Orbitofrontal Cortex (CBOT) for Opioid Use Disorder Phase 2
Completed NCT02391571 - A Study to Evaluate Withdrawal Effects Following Dosing of Oxycodone/Naltrexone in Methadone-Maintained Subjects Phase 3
Recruiting NCT05834478 - Non-invasive Vagal Nerve Stimulation in Opioid Use Disorders UH3 Phase 3
Recruiting NCT05485519 - Prospective, Randomized, Open Label Controlled Trial To Evaluate The Safety And Efficacy Of Dexmedetomidine Use Beyond 24 Hours Compared With Midazolam In Children Admitted To Pediatric Intensive Care Unit at King Abdullah Specialist Children Hospital- Ministry of National Guard Health Affairs. Phase 3